Plasmodium ovale: Everything You Need to Know About This Persistent Malaria Parasite
When most people think of malaria, they think of a single disease. However, malaria is actually caused by several different species of malarial parasites. While Plasmodium falciparum often makes the headlines for being the most dangerous, Plasmodium ovale is a unique and persistent relative that requires a very specific approach to treatment and care.
If you have recently travelled to certain parts of the world or are simply curious about tropical diseases, understanding the nuances of Plasmodium ovale is essential. This parasite has a “hidden” trick up its sleeve that can cause symptoms to reappear months or even years after the initial infection. Let’s dive into the science, the symptoms, and the solutions for this vector-borne illness.
What is Plasmodium ovale?
Plasmodium ovale is one of the five species of the Plasmodium genus that cause malaria in humans. It is primarily found in sub-Saharan Africa, South East Asia, and the Western Pacific. While it is generally considered less “severe” than other types, it is famous in the medical community for its ability to hibernate within the human body.
According to the World Health Organization, malaria remains a significant global health challenge. Plasmodium ovale is unique because it can produce hypnozoites—dormant forms of the parasite that stay in the liver. This dormant liver stage means the person might feel better for a while, only to suffer a relapse later.
The Life Cycle and Transmission
Like its cousins, Plasmodium ovale relies on Anopheles mosquitoes for malaria transmission. When an infected mosquito bites a human, it injects the parasite into the bloodstream. From there, the parasites travel to the liver to mature and multiply before re-entering the blood to infect red blood cells.
Comparing Plasmodium ovale and Plasmodium vivax
Because P. ovale and P. vivax both have a dormant liver stage, they are often compared. However, there are subtle differences in their biology and the endemic regions where they are most commonly found.
| Feature | Plasmodium ovale | Plasmodium vivax |
|---|---|---|
| Geographic Range | West Africa, Philippines, Indonesia | Latin America, Asia, parts of Africa |
| Fever Cycles | Every 48 hours (Tertian) | Every 48 hours (Tertian) |
| Liver Stage | Present (Hypnozoites) | Present (Hypnozoites) |
| Red Blood Cell Preference | Young cells (Reticulocytes) | Young cells (Reticulocytes) |
| Parasitaemia Levels | Typically low | Can be moderate to high |
What are the Symptoms of Plasmodium ovale?
The incubation period for Plasmodium ovale usually ranges from 12 to 20 days, though it can be much longer due to the dormant stage. The symptoms often follow a rhythmic pattern known as fever cycles.
Common symptoms include:
- High fever: Often occurring every 48 hours.
- Rigors: Intense shivering and chills.
- Profuse sweating: Usually occurring as the fever breaks.
- Headache and muscle aches: General malaise similar to a severe flu.
- Fatigue: A feeling of extreme tiredness.
- Nausea: Sometimes accompanied by vomiting or diarrhoea.
While the levels of parasitaemia (the amount of parasite in your blood) are usually lower than in other forms of malaria, the symptoms can still be debilitating and require professional medical attention. If you suspect you have malaria, the NHS recommends seeking urgent medical advice.
How is it Diagnosed?
Diagnosis typically begins with a clinical evaluation of your travel history and symptoms. However, laboratory confirmation is vital. The “gold standard” for diagnosis is the microscopic examination of a blood smear. Experts at the London School of Hygiene & Tropical Medicine utilise both thick and thin blood films to identify the specific shape and characteristics of the P. ovale infected cells, which often appear oval-shaped with “fimbriated” (fringed) edges.
Other diagnostic tools include:
- Rapid Diagnostic Tests (RDTs): These provide quick results but can sometimes miss P. ovale if the parasite density is low.
- PCR (Polymerase Chain Reaction): A highly sensitive molecular test used to distinguish between species.
Treatment Options: Clearing the Blood and the Liver
The goal of treating Plasmodium ovale is twofold: clearing the parasites from the bloodstream and eliminating the hypnozoites from the liver to ensure relapse prevention.
Most strains of P. ovale are chloroquine-sensitive. This means chloroquine is usually the first line of defence for clearing the blood stage. However, as noted by researchers in Nature, the real challenge is the liver stage. To tackle this, doctors typically prescribe Primaquine or Tafenoquine. These medications are specifically designed to target the dormant parasites.
Important Note: Before taking Primaquine, patients must be tested for G6PD deficiency, a genetic condition, as the medication can cause severe anaemia in these individuals. You can learn more about this at the Mayo Clinic.
Prevention and Prophylaxis
If you are travelling to endemic regions, prevention is your best strategy. Because there is no widely available vaccine for Plasmodium ovale specifically, you must rely on chemical prophylaxis and physical barriers.
Experts at the CDC recommend the following “ABCD” approach:
- Awareness: Know the risk in the area you are visiting.
- Bite prevention: Use insect repellent (DEET), wear long-sleeved clothing, and sleep under insecticide-treated nets.
- Chemoprophylaxis: Take antimalarial tablets as prescribed by your doctor or travel clinic.
- Diagnosis: Seek immediate medical help if you develop a fever after returning.
For more specific travel advice, the BMJ and Mahidol Oxford Tropical Medicine Research Unit provide excellent resources for clinicians and travellers alike.
The Future of Malaria Research
Research into Plasmodium ovale continues to evolve. While it was once thought to be a single species, scientists have discovered it actually consists of two subspecies: P. ovale curtisi and P. ovale wallikeri. Understanding these differences is crucial for developing better diagnostic tools and treatments.
Organisations like Gavi, the Vaccine Alliance and the Wellcome Trust are funding research into how these parasites interact with the human immune system. Furthermore, journals such as The Lancet Infectious Diseases and The New England Journal of Medicine frequently publish updates on global efforts to eradicate malaria.
For regional data, the PAHO offers insights into malaria control in the Americas, while clinical guidelines can often be found on Medscape and ScienceDirect.
Frequently Asked Questions (FAQs)
Can Plasmodium ovale be fatal?
While Plasmodium ovale is rarely fatal compared to P. falciparum, it can cause severe illness, especially in people with weakened immune systems, pregnant women, or young children. Complications are rare but possible if left untreated.
How long can Plasmodium ovale stay dormant?
The hypnozoites in the liver can remain dormant for several months, and in some documented cases, up to 4 to 5 years. This is why it is vital to complete the full course of relapse prevention medication like Primaquine.
Is there a vaccine for this type of malaria?
Currently, there is no specific vaccine widely available for Plasmodium ovale. The existing malaria vaccines (like RTS,S) primarily target P. falciparum. Prevention through medication and mosquito avoidance remains the most effective strategy.
Does Plasmodium ovale affect the blood differently?
Yes, under a microscope, P. ovale causes the infected red blood cells to appear slightly larger and often oval-shaped. This distinctive appearance is a key marker for laboratory technicians when performing a blood smear analysis.
